Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CACNA1B | Q00975 | 11/20 | 0.70 |
| ▸ | HRH3 | Q9Y5N1 | 3/20 | 0.52 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.47 |
| ▸ | NPC1 | O15118 | 1/20 | 0.47 |
| ▸ | RAB9A | P51151 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | CCR5 | P51681 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7389506 | 0.94 | CACNA1B (0.67) | CACNA1BHRH3OPRM1KDM4ENPC1 | |
| SCHEMBL7391285 | 0.90 | CACNA1B (0.72) | CACNA1BHRH3KDM4ENPC1RAB9A | |
| SCHEMBL7393936 | 0.89 | CACNA1B (0.66) | CACNA1BKDM4ENPC1RAB9AALDH1A1 | |
| SCHEMBL7390012 | 0.89 | CACNA1B (0.69) | CACNA1BKDM4ENPC1RAB9AALDH1A1 | |
| SCHEMBL7392965 | 0.89 | CACNA1B (0.66) | CACNA1BKDM4ENPC1RAB9AALDH1A1 | |
| SCHEMBL7389836 | 0.89 | CACNA1B (0.69) | CACNA1BKDM4ENPC1RAB9AALDH1A1 | |
| SCHEMBL7395800 | 0.89 | CACNA1B (0.68) | CACNA1BKDM4ENPC1RAB9AALDH1A1 | |
| SCHEMBL7387386 | 0.87 | CACNA1B (0.66) | CACNA1BOPRM1KDM4ENPC1RAB9A | |
| SCHEMBL7385922 | 0.86 | CACNA1B (0.67) | CACNA1BHRH3KDM4ENPC1RAB9A | |
| SCHEMBL7390465 | 0.86 | CACNA1B (0.72) | CACNA1BKDM4ENPC1RAB9AALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6251919-B1 | ADMINISTERING ANILINE DERIVATIVE FOR THERAPY OF PAIN | WARNER-LAMBERT | 2001-06-26 | — | — | US | claimed |
| WO-1999043658-A1 | HETEROCYCLIC SUBSTITUTED ANILINE CALCIUM CHANNEL BLOCKERS | WARNER-LAMBERT COMPANY (US) | 1999-09-02 | — | — | WO | claimed |
| US-6251919-B1 | ADMINISTERING ANILINE DERIVATIVE FOR THERAPY OF PAIN | WARNER-LAMBERT | 2001-06-26 | — | — | US | disclosed |
| WO-1999043658-A1 | HETEROCYCLIC SUBSTITUTED ANILINE CALCIUM CHANNEL BLOCKERS | WARNER-LAMBERT COMPANY (US) | 1999-09-02 | — | — | WO | disclosed |